[HTML] nih.gov

[HTML][HTML] Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma

D Bogen, JS Wei, DO Azorsa, P Ormanoglu… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Despite advances in multimodal treatment, neuroblastoma (NB) is often fatal for children
with high-risk disease and many survivors need to cope with long-term side effects from high …
被引用次数：59 相关文章
[HTML] oncotarget.com

[HTML][HTML] Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma

D Bogen, JS Wei, DO Azorsa, P Ormanoglu, E Buehler… - Oncotarget, 2015 - oncotarget.com
Abstract Dominik Bogen 1, 2,*, Jun S. Wei 1,*, David O. Azorsa 4, Pinar Ormanoglu 3, Eugen
Buehler 3, Rajarshi Guha 3, Jonathan M. Keller 3, Lesley A. Mathews Griner 3, Marc Ferrer …

Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma

D Bogen, JS Wei, DO Azorsa, P Ormanoglu… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Despite advances in multimodal treatment, neuroblastoma (NB) is often fatal for children
with high-risk disease and many survivors need to cope with long-term side effects from high …

Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.

D Bogen, JS Wei, DO Azorsa, P Ormanoglu, E Buehler… - Oncotarget, 2015 - europepmc.org
Despite advances in multimodal treatment, neuroblastoma (NB) is often fatal for children
with high-risk disease and many survivors need to cope with long-term side effects from high …

[引用][C] Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma

D Bogen, JS Wei, DO Azorsa, P Ormanoglu, E Buehler… - Oncotarget, 2015 - cir.nii.ac.jp
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma

D Bogen, JS Wei, DO Azorsa, P Ormanoglu, E Buehler… - Oncotarget, 2015 - oncotarget.com
Abstract Dominik Bogen 1, 2,*, Jun S. Wei 1,*, David O. Azorsa 4, Pinar Ormanoglu 3, Eugen
Buehler 3, Rajarshi Guha 3, Jonathan M. Keller 3, Lesley A. Mathews Griner 3, Marc Ferrer …

Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.

D Bogen, JS Wei, DO Azorsa, P Ormanoglu, E Buehler… - Oncotarget, 2015 - europepmc.org
Despite advances in multimodal treatment, neuroblastoma (NB) is often fatal for children
with high-risk disease and many survivors need to cope with long-term side effects from high …